Glaucocalyxin a protect liver function via inhibiting platelet over-activation during sepsis

GLA can inhibit platelet activation by reducing surface expression of C3aR, which protect the liver from injury induced by excessive complement activation. GLA is a novel therapeutic agent for controlling sepsis-related liver dysfunction.